Status:
COMPLETED
Device-based QRS Evaluation
Lead Sponsor:
Abbott Medical Devices
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to collect simultaneous surface electrocardiogram (ECG) recordings and Cardiac Resynchronization Therapy (CRT) intracardiac electrogram (IEGM) recordings of variations in ...
Eligibility Criteria
Inclusion
- Already implanted with SJM Quadripolar CRT Pacing System
- Ability to provide informed consent for study participation
- Willing to comply with the study evaluation requirements
- At least 18 years of age
Exclusion
- Resting ventricular rate \>100 bpm
- Intrinsic PR interval \> 300 ms
- Paroxysmal or persistent atrial tachycardia or atrial fibrillation documented
- Pregnant or plans to become pregnant during the study
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT02814214
Start Date
June 1 2016
End Date
September 1 2017
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I.R.C.C.S. Policlinico San Donato
San Donato Milanese, MI, Italy, 20097